MEDIFAST Historical Balance Sheet

MED Stock

USD 14.34 0.02 0.14%

Trend analysis of MEDIFAST INC balance sheet accounts such as Total Current Liabilities of 36.9 M provides information on MEDIFAST INC's total assets, liabilities, and equity, which is the actual value of MEDIFAST INC to its prevalent stockholders. By breaking down trends over time using MEDIFAST INC balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining MEDIFAST INC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether MEDIFAST INC is a good buy for the upcoming year.

MEDIFAST INC Inventory

28.42 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

About MEDIFAST Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of MEDIFAST INC at a specified time, usually calculated after every quarter, six months, or one year. MEDIFAST INC Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of MEDIFAST INC and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which MEDIFAST currently owns. An asset can also be divided into two categories, current and non-current.

MEDIFAST INC Balance Sheet Chart

At present, MEDIFAST INC's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 220.6 M, whereas Total Current Liabilities is forecasted to decline to about 36.9 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of MEDIFAST INC assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in MEDIFAST INC books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on MEDIFAST INC balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of MEDIFAST INC are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from MEDIFAST INC's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into MEDIFAST INC current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.At present, MEDIFAST INC's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 220.6 M, whereas Total Current Liabilities is forecasted to decline to about 36.9 M.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	26.1M	22.0M	16.1M	16.9M
Total Assets	316.2M	309.9M	284.2M	298.4M

Short Long Term Debt Total Total Assets

MEDIFAST INC balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Accounts Payable	Other Assets
Total Assets		0.89	0.83	0.87	0.94	0.79	-0.65	0.91	0.81	0.9	0.26	0.65	0.35	0.16	0.17	0.72	0.8	0.52	0.18	0.87	0.88	0.99	0.8	0.16	0.68	0.83
Short Long Term Debt Total	0.89		0.9	0.87	0.76	0.73	-0.48	0.76	0.66	0.81	0.41	0.51	0.21	-0.04	-0.05	0.71	0.86	0.35	0.04	0.87	0.79	0.87	0.72	-0.04	0.76	0.72
Other Current Liab	0.83	0.9		0.97	0.62	0.75	-0.6	0.71	0.73	0.7	0.35	0.66	-0.06	0.0	0.01	0.73	0.89	0.11	-0.18	0.96	0.61	0.84	0.67	0.01	0.79	0.58
Total Current Liabilities	0.87	0.87	0.97		0.64	0.82	-0.6	0.71	0.74	0.74	0.25	0.68	-0.1	0.01	0.04	0.78	0.94	0.09	-0.08	1.0	0.65	0.87	0.66	0.01	0.81	0.57
Total Stockholder Equity	0.94	0.76	0.62	0.64		0.64	-0.64	0.92	0.77	0.84	0.24	0.6	0.61	0.24	0.23	0.53	0.57	0.72	0.33	0.65	0.88	0.93	0.78	0.24	0.51	0.88
Property Plant And Equipment Net	0.79	0.73	0.75	0.82	0.64		-0.25	0.61	0.43	0.91	0.05	0.47	0.09	0.28	0.28	0.95	0.82	0.16	0.17	0.86	0.81	0.72	0.64	0.28	0.61	0.54
Net Debt	-0.65	-0.48	-0.6	-0.6	-0.64	-0.25		-0.72	-0.97	-0.31	-0.31	-0.89	-0.11	-0.12	-0.17	-0.09	-0.36	-0.25	0.07	-0.54	-0.29	-0.74	-0.51	-0.12	-0.51	-0.55
Retained Earnings	0.91	0.76	0.71	0.71	0.92	0.61	-0.72		0.83	0.74	0.24	0.7	0.44	0.25	0.29	0.5	0.6	0.57	-0.02	0.7	0.75	0.93	0.69	0.25	0.56	0.74
Cash	0.81	0.66	0.73	0.74	0.77	0.43	-0.97	0.83		0.51	0.35	0.87	0.2	0.1	0.13	0.3	0.53	0.36	-0.01	0.7	0.5	0.88	0.67	0.1	0.58	0.7
Non Current Assets Total	0.9	0.81	0.7	0.74	0.84	0.91	-0.31	0.74	0.51		0.15	0.39	0.42	0.21	0.19	0.86	0.74	0.51	0.33	0.78	0.98	0.82	0.78	0.21	0.53	0.8
Non Currrent Assets Other	0.26	0.41	0.35	0.25	0.24	0.05	-0.31	0.24	0.35	0.15		0.22	0.13	-0.05	-0.23	0.06	0.22	0.13	0.11	0.23	0.18	0.29	0.31	-0.05	0.24	0.31
Cash And Short Term Investments	0.65	0.51	0.66	0.68	0.6	0.47	-0.89	0.7	0.87	0.39	0.22		0.05	0.17	0.24	0.28	0.44	0.02	-0.1	0.64	0.32	0.71	0.57	0.17	0.59	0.45
Net Receivables	0.35	0.21	-0.06	-0.1	0.61	0.09	-0.11	0.44	0.2	0.42	0.13	0.05		0.03	-0.07	0.03	-0.16	0.85	0.46	-0.09	0.58	0.31	0.55	0.03	-0.23	0.67
Common Stock Total Equity	0.16	-0.04	0.0	0.01	0.24	0.28	-0.12	0.25	0.1	0.21	-0.05	0.17	0.03		0.94	0.21	0.01	0.1	0.04	0.03	0.13	0.13	-0.14	1.0	0.17	-0.03
Common Stock Shares Outstanding	0.17	-0.05	0.01	0.04	0.23	0.28	-0.17	0.29	0.13	0.19	-0.23	0.24	-0.07	0.94		0.18	0.03	0.02	-0.06	0.06	0.09	0.15	-0.19	0.94	0.22	-0.09
Non Current Liabilities Total	0.72	0.71	0.73	0.78	0.53	0.95	-0.09	0.5	0.3	0.86	0.06	0.28	0.03	0.21	0.18		0.84	0.13	0.13	0.83	0.76	0.64	0.6	0.21	0.55	0.47
Inventory	0.8	0.86	0.89	0.94	0.57	0.82	-0.36	0.6	0.53	0.74	0.22	0.44	-0.16	0.01	0.03	0.84		0.08	-0.01	0.95	0.66	0.79	0.53	0.01	0.81	0.47
Other Current Assets	0.52	0.35	0.11	0.09	0.72	0.16	-0.25	0.57	0.36	0.51	0.13	0.02	0.85	0.1	0.02	0.13	0.08		0.41	0.1	0.66	0.49	0.48	0.1	-0.07	0.76
Other Stockholder Equity	0.18	0.04	-0.18	-0.08	0.33	0.17	0.07	-0.02	-0.01	0.33	0.11	-0.1	0.46	0.04	-0.06	0.13	-0.01	0.41		-0.05	0.41	0.13	0.27	0.04	-0.06	0.41
Total Liab	0.87	0.87	0.96	1.0	0.65	0.86	-0.54	0.7	0.7	0.78	0.23	0.64	-0.09	0.03	0.06	0.83	0.95	0.1	-0.05		0.68	0.86	0.67	0.03	0.79	0.58
Property Plant And Equipment Gross	0.88	0.79	0.61	0.65	0.88	0.81	-0.29	0.75	0.5	0.98	0.18	0.32	0.58	0.13	0.09	0.76	0.66	0.66	0.41	0.68		0.81	0.8	0.13	0.44	0.87
Total Current Assets	0.99	0.87	0.84	0.87	0.93	0.72	-0.74	0.93	0.88	0.82	0.29	0.71	0.31	0.13	0.15	0.64	0.79	0.49	0.13	0.86	0.81		0.78	0.13	0.7	0.81
Short Term Debt	0.8	0.72	0.67	0.66	0.78	0.64	-0.51	0.69	0.67	0.78	0.31	0.57	0.55	-0.14	-0.19	0.6	0.53	0.48	0.27	0.67	0.8	0.78		-0.14	0.31	0.86
Common Stock	0.16	-0.04	0.01	0.01	0.24	0.28	-0.12	0.25	0.1	0.21	-0.05	0.17	0.03	1.0	0.94	0.21	0.01	0.1	0.04	0.03	0.13	0.13	-0.14		0.17	-0.03
Accounts Payable	0.68	0.76	0.79	0.81	0.51	0.61	-0.51	0.56	0.58	0.53	0.24	0.59	-0.23	0.17	0.22	0.55	0.81	-0.07	-0.06	0.79	0.44	0.7	0.31	0.17		0.35
Other Assets	0.83	0.72	0.58	0.57	0.88	0.54	-0.55	0.74	0.7	0.8	0.31	0.45	0.67	-0.03	-0.09	0.47	0.47	0.76	0.41	0.58	0.87	0.81	0.86	-0.03	0.35

Click cells to compare fundamentals

MEDIFAST INC Account Relationship Matchups

MEDIFAST INC balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	276.1M	398.3M	316.2M	309.9M	284.2M	298.4M
Short Long Term Debt Total	11.2M	32.5M	26.1M	22.0M	16.1M	16.9M
Other Current Liab	57.3M	84.4M	69.1M	48.5M	33.1M	18.1M
Total Current Liabilities	111.4M	169.8M	140.9M	92.3M	64.2M	36.9M
Total Stockholder Equity	157.2M	202.5M	155.0M	201.5M	210.1M	220.6M
Property Plant And Equipment Net	38.1M	80.6M	75.6M	67.1M	48.7M	28.0M
Net Debt	(152.6M)	(71.6M)	(61.6M)	(72.4M)	(74.8M)	(71.1M)
Retained Earnings	154.4M	190.3M	139.9M	174.6M	176.8M	185.6M
Cash	163.7M	104.2M	87.7M	94.4M	90.9M	95.5M
Non Current Assets Total	41.8M	91.5M	93.4M	85.9M	69.8M	73.3M
Non Currrent Assets Other	2.9M	6.5M	12.5M	14.7M	9.7M	10.2M
Cash And Short Term Investments	174.5M	109.5M	87.7M	150.0M	90.9M	50.9M
Net Receivables	1.4M	584K	0.0	8.7M	10.0M	10.5M
Common Stock Shares Outstanding	11.9M	11.8M	11.3M	10.9M	11.0M	12.2M
Liabilities And Stockholders Equity	276.1M	398.3M	316.2M	309.9M	284.2M	298.4M
Non Current Liabilities Total	7.5M	26.0M	20.3M	16.1M	9.9M	7.1M
Inventory	53.4M	180.0M	118.9M	54.6M	42.4M	28.4M
Other Current Assets	12.3M	17.3M	16.2M	19.4M	81.1M	85.1M
Other Stockholder Equity	2.8M	12.0M	15.2M	26.6M	33.1M	34.8M
Total Liab	118.8M	195.9M	161.2M	108.4M	74.1M	43.9M
Property Plant And Equipment Gross	38.1M	113.3M	115.6M	114.4M	107.0M	112.4M
Total Current Assets	234.3M	306.9M	222.8M	224.0M	214.4M	225.1M
Short Term Debt	7.3M	6.5M	5.8M	11.8M	6.2M	6.5M
Accounts Payable	36.1M	70.9M	58.7M	39.2M	23.1M	21.5M
Accumulated Other Comprehensive Income	41K	111K	24K	248K	180K	189K
Other Assets	1.7M	14.1M	10.9M	17.8M	20.5M	21.5M
Short Term Investments	10.8M	5.4M	(23K)	55.6M	71.4M	75.0M
Property Plant Equipment	26.0M	27.6M	56.1M	57.2M	65.8M	69.1M
Current Deferred Revenue	7.6M	8.1M	7.4M	574K	316K	300.2K
Net Tangible Assets	104.8M	157.2M	202.5M	155.0M	178.3M	125.0M
Retained Earnings Total Equity	168.8M	154.4M	190.3M	139.9M	160.8M	126.9M
Capital Surpluse	0.0	7.8M	12.0M	21.6M	19.4M	10.8M
Capital Lease Obligations	11.2M	32.5M	26.1M	22.0M	16.1M	15.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:

How To Invest In MEDIFAST

Details

Is MEDIFAST Stock a good investment?

Details

What is MEDIFAST INC's Net Worth?

Details

Largest Personal Care Products Companies

View

Largest Household & Personal Products Companies

View

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.87)

Earnings Share

0.19

Revenue Per Share

55.12

Quarterly Revenue Growth

(0.38)

Return On Assets

0.0324

The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

MEDIFAST Historical Balance Sheet

MEDIFAST INC Inventory

28.42 Million

About MEDIFAST Balance Sheet Analysis

MEDIFAST INC Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

MEDIFAST INC balance sheet Correlations

MEDIFAST INC Account Relationship Matchups

High Positive Relationship

High Negative Relationship

MEDIFAST INC balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Current Liabilities
Common Stock	+ 1.0	Common Stock Total Equity
Total Current Assets	+ 0.99	Total Assets
Property Plant And Equipment Gross	+ 0.98	Non Current Assets Total
Total Current Liabilities	+ 0.97	Other Current Liab
Total Liab	+ 0.96	Other Current Liab

Cash	- 0.97	Net Debt
Cash And Short Term Investments	- 0.89	Net Debt
Total Current Assets	- 0.74	Net Debt
Retained Earnings	- 0.72	Net Debt
Net Debt	- 0.65	Total Assets
Net Debt	- 0.64	Total Stockholder Equity